3-[2-oxo-2-[2-[[5-(1H-pyrazol-4-yl)indazol-1-yl]methyl]-7-azabicyclo[2.2.1]heptan-7-yl]ethyl]benzonitrile
C26H24N6O — CID 118682260
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-oxo-2-[2-[[5-(1H-pyrazol-4-yl)indazol-1-yl]methyl]-7-azabicyclo[2.2.1]heptan-7-yl]ethyl]benzonitrile
3-[2-oxo-2-[2-[[5-(1H-pyrazol-4-yl)indazol-1-yl]methyl]-7-azabicyclo[2.2.1]heptan-7-yl]ethyl]benzonitrile (PubChem CID 118682260) has the molecular formula C26H24N6O and a molecular weight of 436.52 g/mol. Its IUPAC name is 3-[2-oxo-2-[2-[[5-(1H-pyrazol-4-yl)indazol-1-yl]methyl]-7-azabicyclo[2.2.1]heptan-7-yl]ethyl]benzonitrile.
Molecular Properties
| Compound Name | 3-[2-oxo-2-[2-[[5-(1H-pyrazol-4-yl)indazol-1-yl]methyl]-7-azabicyclo[2.2.1]heptan-7-yl]ethyl]benzonitrile |
|---|---|
| PubChem CID | 118682260 |
| Molecular Formula | C26H24N6O |
| Molecular Weight | 436.52 g/mol |
| Exact Mass | 436.20 |
| IUPAC Name | 3-[2-oxo-2-[2-[[5-(1H-pyrazol-4-yl)indazol-1-yl]methyl]-7-azabicyclo[2.2.1]heptan-7-yl]ethyl]benzonitrile |
| SMILES | N#Cc1cccc(CC(=O)N2C3CCC2C(Cn2ncc4cc(-c5cn[nH]c5)ccc42)C3)c1 |
| InChI | InChI=1S/C26H24N6O/c27-12-18-3-1-2-17(8-18)9-26(33)32-23-5-7-25(32)21(11-23)16-31-24-6-4-19(10-20(24)15-30-31)22-13-28-29-14-22/h1-4,6,8,10,13-15,21,23,25H,5,7,9,11,16H2,(H,28,29) |
| InChIKey | KCYPOSIGYCILNC-UHFFFAOYSA-N |
| XLogP | 3.92 |
| TPSA | 90.60 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.52 |
| LogP ≤ 5 | 3.92 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118682260 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.